276 related articles for article (PubMed ID: 29663088)
41. [Kidney calculi--is nutrition a trigger or treatment?].
Wahl C; Hess B
Ther Umsch; 2000 Mar; 57(3):138-45. PubMed ID: 10756693
[TBL] [Abstract][Full Text] [Related]
42. Which Diet for Calcium Stone Patients: A Real-World Approach to Preventive Care.
D'Alessandro C; Ferraro PM; Cianchi C; Barsotti M; Gambaro G; Cupisti A
Nutrients; 2019 May; 11(5):. PubMed ID: 31137803
[TBL] [Abstract][Full Text] [Related]
43. Diet and renal stone formation.
Trinchieri A
Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
[TBL] [Abstract][Full Text] [Related]
44. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms.
Nirumand MC; Hajialyani M; Rahimi R; Farzaei MH; Zingue S; Nabavi SM; Bishayee A
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518971
[TBL] [Abstract][Full Text] [Related]
45. When and how to evaluate a patient with nephrolithiasis.
Rivers K; Shetty S; Menon M
Urol Clin North Am; 2000 May; 27(2):203-13. PubMed ID: 10778464
[TBL] [Abstract][Full Text] [Related]
46. Nutritional Management of Kidney Stones (Nephrolithiasis).
Han H; Segal AM; Seifter JL; Dwyer JT
Clin Nutr Res; 2015 Jul; 4(3):137-52. PubMed ID: 26251832
[TBL] [Abstract][Full Text] [Related]
47. Clinical approach to adults.
Monk RD
Semin Nephrol; 1996 Sep; 16(5):375-88. PubMed ID: 8890394
[TBL] [Abstract][Full Text] [Related]
48. Medical management of kidney stones: AUA guideline.
Pearle MS; Goldfarb DS; Assimos DG; Curhan G; Denu-Ciocca CJ; Matlaga BR; Monga M; Penniston KL; Preminger GM; Turk TM; White JR;
J Urol; 2014 Aug; 192(2):316-24. PubMed ID: 24857648
[TBL] [Abstract][Full Text] [Related]
49. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
50. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
Hess B
Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
[TBL] [Abstract][Full Text] [Related]
51. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
[TBL] [Abstract][Full Text] [Related]
52. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice.
Mardis HK; Parks JH; Muller G; Ganzel K; Coe FL
J Urol; 2004 Jan; 171(1):85-8. PubMed ID: 14665850
[TBL] [Abstract][Full Text] [Related]
53. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
[TBL] [Abstract][Full Text] [Related]
54. Metabolic evaluation of stone disease patients: a practical approach.
Lifshitz DA; Shalhav AL; Lingeman JE; Evan AP
J Endourol; 1999 Nov; 13(9):669-78. PubMed ID: 10608520
[TBL] [Abstract][Full Text] [Related]
55. Kidney Stones: Treatment and Prevention.
Fontenelle LF; Sarti TD
Am Fam Physician; 2019 Apr; 99(8):490-496. PubMed ID: 30990297
[TBL] [Abstract][Full Text] [Related]
56. Dietary and holistic treatment of recurrent calcium oxalate kidney stones: review of literature to guide patient education.
Flagg LR
Urol Nurs; 2007 Apr; 27(2):113-22, 143; quiz 123. PubMed ID: 17494450
[TBL] [Abstract][Full Text] [Related]
57. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
[TBL] [Abstract][Full Text] [Related]
58. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.
Raj GV; Auge BK; Assimos D; Preminger GM
J Endourol; 2004 Mar; 18(2):157-61. PubMed ID: 15072623
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of hypocitraturia in kidney stone patients.
Matsushita K; Tanikawa K; Masuda A; Matsuzaki S
Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138
[TBL] [Abstract][Full Text] [Related]
60. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
